cabazitaxel,lutetium lu 177 vipivotide tetraxetan
novartis,sanofi,emcure
['therap ', 'novartis']
some more press on on our #therap study 3 year results presented #asco22 
The Australian and New Zealand Urogenital and Prostate cancer trials group aims to develop, foster and promote prostate and other urogenital cancer research